Fig. 3From: Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysisForest plots of abacavir-containing regimen versus other nucleoside reverse transcriptase inhibitors (cohort studies)Back to article page